Source comparison
Sermorelin vs Other Growth Hormone Secretagogues
Sermorelin belongs to a family of compounds called growth hormone secretagogues (GHS). Understanding where it sits within this family helps clarify why it is sometimes confused not only with steroids but also with other GH-related compounds. CJC-1295 is a modi
This comparison does not assign a generated winner or score.
- Sermorelin belongs to a family of compounds called growth hormone secretagogues (GHS). Understanding where it sits within this family helps clarify why it is sometimes confused not only with steroids but also with other GH-related compounds.
- CJC-1295 is a modified GHRH analog with a much longer half-life (days vs minutes) due to drug affinity complex (DAC) technology. It binds the same GHRH receptor as sermorelin but provides sustained rather than pulsatile GH release. Use our CJC-1295 + Ipamorelin dosage calculator for dosing guidance.
- Ipamorelin is a growth hormone-releasing peptide (GHRP) that works through the ghrelin receptor, not the GHRH receptor. It complements sermorelin by stimulating GH release through a separate pathway. The two are frequently stacked for synergistic effects. See our peptide stacking guide for combination protocols.
- MK-677 (ibutamoren) is an oral growth hormone secretagogue that also acts through the ghrelin receptor. It is not technically a peptide but a non-peptide mimetic. Its oral bioavailability and 24-hour half-life make it convenient but also more likely to produce side effects like increased appetite and water retention.
- GHRP-6 is another ghrelin receptor agonist with potent GH-releasing effects but significantly more appetite stimulation than ipamorelin or sermorelin. Hexarelin is the most potent GHRP but carries a higher risk of cortisol and prolactin elevation. For hexarelin-specific dosing, see our hexarelin dosage guide.
- HGH Fragment 176-191 is a modified fragment of human growth hormone itself, not a secretagogue. It targets fat metabolism without the growth-promoting effects of full-length GH. Despite containing part of the GH molecule, it is still a peptide, not a steroid.
- None of these compounds are steroids. None bind androgen receptors. None suppress the HPTA. They represent a pharmacologically distinct category that happens to influence some of the same endpoints (body composition, recovery, anti-aging) through entirely different pathways.